<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.0.0 (http://www.squarespace.com/) on Wed, 07 Jan 2009 01:08:06 GMT--><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rss="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:cc="http://web.resource.org/cc/"><rss:channel rdf:about="http://brainscienceblogs.com/negative-failed-clinical-tria/"><rss:title>Negative &amp; Failed Clinical Trial Reports</rss:title><rss:link>http://brainscienceblogs.com/negative-failed-clinical-tria/</rss:link><rss:description></rss:description><dc:language>en-US</dc:language><dc:date>2009-01-07T01:08:06Z</dc:date><admin:generatorAgent rdf:resource="http://www.squarespace.com/">Squarespace Site Server v5.0.0 (http://www.squarespace.com/)</admin:generatorAgent><rss:items><rdf:Seq><rdf:li rdf:resource="http://brainscienceblogs.com/negative-failed-clinical-tria/2008/3/25/negative-failed-clinical-trial-reports.html"/></rdf:Seq></rss:items></rss:channel><rss:item rdf:about="http://brainscienceblogs.com/negative-failed-clinical-tria/2008/3/25/negative-failed-clinical-trial-reports.html"><rss:title>Negative &amp; Failed Clinical Trial Reports</rss:title><rss:link>http://brainscienceblogs.com/negative-failed-clinical-tria/2008/3/25/negative-failed-clinical-trial-reports.html</rss:link><dc:creator>Contacts</dc:creator><dc:date>2008-03-25T21:45:10Z</dc:date><dc:subject>Negative &amp; Failed Clinical Trial Reports</dc:subject><content:encoded><![CDATA[<p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=22" target="_blank">An Open-Label Study of Tiagabine in Panic Disorder<br />By David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, B. Ashok Raj, MD,and Juris Janavs, MD</a></p><p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=22" target="_blank">Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial<br />By Gahan J. Pandina, PhD, Carla M. Canuso, MD, Ibrahim Turkoz, MS, Mary Kujawa, MD, PhD, <br />and Ramy A. Mahmoud, MD, MPH </a><br /></p>
]]></content:encoded></rss:item></rdf:RDF>